Clinical trial on Psoriasis
Phase 2
Completed
- Conditions
- Health Condition 1: null- Psoriasis
- Registration Number
- CTRI/2018/05/013636
- Lead Sponsor
- Central Council for Research in Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Apparent psoriatic lesions of the body.
Exclusion Criteria
1. Patients with psoriatic arthritis
2. Patients suffering with other skin diseases
3. Serious systemic diseases
4. Pregnant and lactating mothers
5. Patient unsure about attending treatment schedule regularly and those who do not have a suitable place for sun exposure.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clearance of psoriasis in terms of PASI scoring or 6 months of treatment which ever is earlier.Timepoint: Baseline, 1st month, 2nd, 3rd, 4th, 5th, 6th
- Secondary Outcome Measures
Name Time Method Assessment of Safety in terms of LFT and RFTTimepoint: Baseline, Monthly follow ups for 6 months